Research Insight

Researchers Uncover Anti-Cancer Compounds In The Corals

The ocean below is filled with riddles, but scientists have recently discovered one of its best-kept mysteries. For the past 25 years, researchers have been looking for the origin of a natural chemical that has shown promise in preliminary...

New Molecular Target For Cancer Therapy Found Through Study

The Ohio State University Comprehensive Cancer Center, Richard J. Solove Research Institute, and James Cancer Hospital have discovered a new molecular therapeutic target that could lead to the development of new cancer treatments with fewer side effects. Previous research has...

New study demonstrates advantages of PentaHibe for cryopreservation of T cells

New data published by Haastrup EK. et. al in Transfusion and Apheresis Science1 demonstrates the efficacy of PentaHibe® in cryopreservation of T cells. PentaHibe® (pentaisomaltose), a GMP excipient for cell therapies, is a new alternative cryoprotective agent for most cell...

Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study

Alternating doses of the Oxford-AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against COVID-19, according to researchers running the University of Oxford-led Com-COV study. In a paper published on the Lancet pre-print server, they report that both ‘mixed’ schedules (Pfizer-BioNTech...

A ‘Single Dose’ of vaccine sufficient for those already infected with COVID-19, says AIG Study

During the second COVID wave when cases were growing exponentially; unfortunately, the vaccination rate took a downturn. As of 27th April, when the growth rate of active infection was ~5% and the growth of vaccinated people was just 1.4%....

Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody

Aevi Genomic Medicine, Inc. announced that it has obtained the right to exercise an exclusive global license for MEDI2338, a Phase 2-ready fully human monoclonal antibody (mAb) that targets interleukin 18 (IL-18). The Company plans to initially develop MEDI2338...

Navigating Russia’s Compliance Regulations; Arguably the Most Complex in the World

Russia’s increasing reliance on pharmaceutical-driven healthcare is resulting in a growing consumer demand for drugs of all types. Over the past few decades, the country’s domestic pharmaceutical market has shifted, maturing into a model more closely aligned with those of...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read